EACS 2011: Multiple Regimens Are Used for First-Line HIV Treatment, but Outcomes Are Similar
- Details
- Category: HIV Treatment
- Published on Friday, 28 October 2011 00:00
- Written by Liz Highleyman
Initial antiretroviral therapy (ART) regimens vary widely according to patient characteristics and provider preferences, but most commonly used multi-class combination regimens appear to work about equally well, according to research presented at the 13th European AIDS Conference (EACS 2011) this month in Belgrade.
EACS 2011: Does Maraviroc Intensification Promote Better CD4 Cell Recovery?
- Details
- Category: HIV Treatment
- Published on Tuesday, 25 October 2011 00:00
- Written by Liz Highleyman
Adding maraviroc (Selzentry or Celsentri) to a suppressive antiretroviral regimen may help promote CD4 T-cell recovery in a subset of patients who experience poor immunological response to treatment, according to 2 studies presented at the 13th European AIDS Conference (EACS 2011) this month in Belgrade.
Guidelines Galore: U.S. and EACS Update HIV Recommendations, AASLD Revision Adds New HCV Drugs
- Details
- Category: HIV Treatment
- Published on Tuesday, 18 October 2011 00:00
- Written by Liz Highleyman
On October 14, 2011, the U.S. Department of Health and Human Services (DHHS) issued updated guidelines for the use of antiretroviral therapy in adults and adolescents.
The European AIDS Clinical Society (EACS) released revised guidelines the same day at the 13th European AIDS Conference in Belgrade.
EACS 2011: Predictors of HCV Viral Load in HIV/HCV Coinfected Patients
- Details
- Category: HCV Treatment
- Published on Tuesday, 25 October 2011 00:00
- Written by Liz Highleyman
Hepatitis C virus (HCV) RNA levels rise over time in HIV/HCV coinfected people, reducing the chances of sustained response to interferon-based treatment. But antiretroviral therapy may help control HCV viral load and contribute to higher likelihood of treatment success, according to a report presented at the 13th European AIDS Conference (EACS 2011) this month in Belgrade.
New Guidance Addresses Expanded Antiretroviral Treatment, Perinatal ART, and PrEP
- Details
- Category: HIV Treatment
- Published on Monday, 17 October 2011 00:00
- Written by Liz Highleyman
On October 14, 2011, the U.S. Department of Health and Human Services (DHHS) issued updated guidelines for the use of antiretroviral therapy in adults and adolescents.
The European AIDS Clinical Society (EACS) released revised guidelines the same day at the 13th European AIDS Conference in Belgrade.
The American Association for the Study of the Liver (AASLD) this month released new guidelines for the treatment of genotype 1 chronic hepatitis C, including information about boceprevir (Victrelis) and telaprevir (Incivek).
More Articles...
- EACS 2011: Switching from Efavirenz to Rilpivirine Single Tablet Regimen Is Safe and Effective
- EACS 2011: IL28B Gene Variant that Helps Hepatitis C Treatment May Hinder HIV Treatment
- EACS 2011: Antiretroviral Therapy Reduces Liver Fibrosis Progression in HIV/HCV Coinfected People
- EACS 2011: Incidence of Non-AIDS Malignancies Stabilizes in D:A:D Study, but Prognosis Improves
Web Design and Development by